Silvant Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $100K | Hold |
257
| – | – | ﹤0.01% | 221 |
|
2025
Q1 | $112K | Hold |
257
| – | – | 0.01% | 215 |
|
2024
Q4 | $94.8K | Hold |
257
| – | – | ﹤0.01% | 226 |
|
2024
Q3 | $134K | Hold |
257
| – | – | 0.01% | 202 |
|
2024
Q2 | $139K | Hold |
257
| – | – | 0.01% | 190 |
|
2024
Q1 | $133K | Hold |
257
| – | – | 0.01% | 198 |
|
2023
Q4 | $121K | Hold |
257
| – | – | 0.01% | 197 |
|
2023
Q3 | $112K | Hold |
257
| – | – | 0.01% | 196 |
|
2023
Q2 | $114K | Hold |
257
| – | – | 0.01% | 200 |
|
2023
Q1 | $118K | Hold |
257
| – | – | 0.01% | 191 |
|
2022
Q4 | $132K | Hold |
257
| – | – | 0.01% | 185 |
|
2022
Q3 | $117K | Hold |
257
| – | – | 0.01% | 234 |
|
2022
Q2 | $124K | Hold |
257
| – | – | 0.03% | 192 |
|
2022
Q1 | $126K | Hold |
257
| – | – | 0.02% | 208 |
|
2021
Q4 | $119K | Hold |
257
| – | – | 0.02% | 210 |
|
2021
Q3 | $96K | Hold |
257
| – | – | 0.02% | 229 |
|
2021
Q2 | $98K | Hold |
257
| – | – | 0.02% | 236 |
|
2021
Q1 | $92K | Hold |
257
| – | – | 0.02% | 239 |
|
2020
Q4 | $83K | Hold |
257
| – | – | 0.01% | 238 |
|
2020
Q3 | $69K | Hold |
257
| – | – | 0.01% | 236 |
|
2020
Q2 | $68K | Hold |
257
| – | – | 0.01% | 237 |
|
2020
Q1 | $58K | Hold |
257
| – | – | 0.01% | 229 |
|
2019
Q4 | $78K | Hold |
257
| – | – | 0.01% | 241 |
|
2019
Q3 | $62K | Sell |
257
-56
| -18% | -$13.5K | 0.01% | 250 |
|
2019
Q2 | $88K | Hold |
313
| – | – | 0.02% | 244 |
|
2019
Q1 | $90K | Hold |
313
| – | – | 0.02% | 237 |
|
2018
Q4 | $82K | Hold |
313
| – | – | 0.02% | 236 |
|
2018
Q3 | $86K | Hold |
313
| – | – | 0.01% | 249 |
|
2018
Q2 | $75K | Hold |
313
| – | – | 0.01% | 260 |
|
2018
Q1 | $69K | Buy |
+313
| New | +$69K | 0.01% | 271 |
|